35
Views
12
CrossRef citations to date
0
Altmetric
Review

Photoallergy

Pages 263-270 | Published online: 10 Jan 2014

References

  • Tokura Y. Immune responses to photohaptens: implications for the mechanisms of photosensitivity to exogenous agents. J. Dermatol. Sci.23(Suppl. 1), S6–S9 (2000).
  • Schwarz KJ. [Experimental studies on sulfanilamide and chlorpromazine photoallergy]. Dermatologica139(Suppl. 1), 1 (1969).
  • Kondo S, Kagaya M, Yamada Y, Matsusaka H, Jimbow K. UVB photosensitivity due to ranitidine. Dermatology201(1), 71–73 (2000).
  • Tokura Y, Iwamoto Y, Mizutani K, Takigawa M. Sparfloxacin phototoxicity: potential photoaugmentation by ultraviolet A and B sources. Arch. Dermatol. Res.288(1), 45–50 (1996).
  • Tokura Y, Satoh T, Takigawa M, Yamada M. Genetic control of contact photosensitivity to tetrachlorosalicylanilide. I. Preferential activation of suppressor T cells in low responder H-2k mice. J. Invest. Dermatol.94(4), 471–476 (1990).
  • Tokura Y. Quinolone photoallergy: photosensitivity dermatitis induced by systemic administration of photohaptenic drugs. J. Dermatol. Sci.18(1), 1–10 (1998).
  • Yagi H, Tokura Y, Wakita H, Furukawa F, Takigawa M. TCRV β 7+ Th2 cells mediate UVB-induced suppression of murine contact photosensitivity by releasing IL-10. J. Immunol.156(5), 1824–1831 (1996).
  • Edelson RL. Sezary syndrome, cutaneous T-cell lymphoma, and extracorporeal photopheresis. Arch. Dermatol.135(5), 600–601 (1999).
  • Sauvaigo S, Douki T, Odin F, Caillat S, Ravanat JL, Cadet J. Analysis of fluoroquinolone-mediated photosensitization of 2´-deoxyguanosine, calf thymus and cellular DNA: determination of type-I, type-II and triplet-triplet energy transfer mechanism contribution. Photochem. Photobiol.73(3), 230–237 (2001).
  • Kurita M, Shimauchi T, Kobayashi M, Atarashi K, Mori K, Tokura Y. Induction of keratinocyte apoptosis by photosensitizing chemicals plus UVA. J. Dermatol. Sci.45(2), 105–112 (2007).
  • Commission Directive 2000/33/EC. Official Journal of the European CommunitiesL136/190–L136/107 (2000).
  • Ray RS, Agrawal N, Sharma A, Hans RK. Use of L-929 cell line for phototoxicity assessment. Toxicol. In Vitro22(7), 1775–1781 (2008).
  • Tokura Y, Ogai M, Yagi H, Takigawa M. Afloqualone photosensitivity: immunogenicity of afloqualone-photomodified epidermal cells. Photochem. Photobiol.60(3), 262–267 (1994).
  • Schnyder B, Pichler WJ. Mechanisms of drug-induced allergy. Mayo Clin. Proc.84(3), 268–272 (2009).
  • Tokura Y, Nishijima T, Yagi H, Furukawa F, Takigawa M. Photohaptenic properties of fluoroquinolones. Photochem. Photobiol.64(5), 838–844 (1996).
  • Stein KR, Scheinfeld NS. Drug-induced photoallergic and phototoxic reactions. Expert Opin. Drug Saf.6(4), 431–443 (2007).
  • Epstein JH. Phototoxicity and photoallergy in man. J. Am. Acad. Dermatol.8(2), 141–147 (1983).
  • Harber LC, Harris H, Baer RL. Photoallergic contact dermatitis. Due to halogenated salicylanilides and related compounds. Arch. Dermatol.94(3), 255–262 (1966).
  • Giovinazzo VJ, Harber LC, Bickers DR, Armstrong RB, Silvers DN. Photoallergic contact dermatitis to musk ambrette. Histopathologic features of photobiologic reactions observed in a persistent light reactor. Arch. Dermatol.117(6), 344–348 (1981).
  • Bosca F, Miranda MA. Photosensitizing drugs containing the benzophenone chromophore. J. Photochem. Photobiol. B43(1), 1–26 (1998).
  • Devleeschouwer V, Roelandts R, Garmyn M, Goossens A. Allergic and photoallergic contact dermatitis from ketoprofen: results of (photo) patch testing and follow-up of 42 patients. Contact Dermatitis58(3), 159–166 (2008).
  • Fujita H, Matsuo I. Type I lipid photo-oxidation by the nonsteroidal anti-inflammatory drug suprofen: a possible key to its photosensitivity. Photodermatol. Photoimmunol. Photomed.9(5), 203–208 (1992).
  • Asensio T, Sanchis ME, Sanchez P, Vega JM, Garcia JC. Photocontact dermatitis because of oral dexketoprofen. Contact Dermatitis58(1), 59–60 (2008).
  • Lopez-Abad R, Paniagua MJ, Botey E, Gaig P, Rodriguez P, Richart C. Topical dexketoprofen as a cause of photocontact dermatitis. J. Investig. Allergol. Clin. Immunol.14(3), 247–249 (2004).
  • Fernandez-Jorge B, Goday Bujan JJ, Paradela S, Mazaira M, Fonseca E. Consort photocontact dermatitis from piketoprofen. Contact Dermatitis58(2), 113–115 (2008).
  • Kowalzick L, Ziegler H. Photoallergic contact dermatitis from topical diclofenac in solaraze gel. Contact Dermatitis54(6), 348–349 (2006).
  • Gimenez-Arnau A, Gilaberte M, Conde D, Espona M, Pujol RM. Combined photocontact dermatitis to benzydamine hydrochloride and the emulsifiers, Span 60 and Tween 60 contained in Tantum cream. Contact Dermatitis57(1), 61–62 (2007).
  • Collaris EJ, Frank J. Photoallergic contact dermatitis caused by ultraviolet filters in different sunscreens. Int. J. Dermatol.47(Suppl. 1), 35–37 (2008).
  • Parry EJ, Bilsland D, Morley WN. Photocontact allergy to 4-tert.butyl-4´-methoxy-dibenzoylmethane (Parsol 1789). Contact Dermatitis32(4), 251–252 (1995).
  • Journe F, Marguery MC, Rakotondrazafy J, El Sayed F, Bazex J. Sunscreen sensitization: a 5-year study. Acta Derm. Venereol.79(3), 211–213 (1999).
  • Maier T, Korting HC. Sunscreens – which and what for? Skin Pharmacol. Physiol.18(6), 253–262 (2005).
  • Takigawa M, Miyachi Y. Mechanisms of contact photosensitivity in mice: I. T cell regulation of contact photosensitivity to tetrachlorosalicylanilide under the genetic restrictions of the major histocompatibility complex. J. Invest. Dermatol.79(2), 108–115 (1982).
  • Miyachi Y, Takigawa M. Mechanisms of contact photosensitivity in mice. III. Predictive testing of chemicals with photoallergenic potential in mice. Arch. Dermatol.119(9), 736–739 (1983).
  • Imai S, Atarashi K, Ikesue K, Akiyama K, Tokura Y. Establishment of murine model of allergic photocontact dermatitis to ketoprofen and characterization of pathogenic T cells. J. Dermatol. Sci.41(2), 127–136 (2006).
  • Atarashi K, Kabashima K, Akiyama K, Tokura Y. Stimulation of Langerhans cells with ketoprofen plus UVA in murine photocontact dermatitis to ketoprofen. J. Dermatol. Sci.47(2), 151–159 (2007).
  • Gerberick GF, Ryan CA, Von Bargen EC, Stuard SB, Ridder GM. Examination of tetrachlorosalicylanilide (TCSA) photoallergy using in vitro photohapten-modified Langerhans cell-enriched epidermal cells. J. Invest. Dermatol.97(2), 210–218 (1991).
  • Gerberick GF, Ryan CA, Fletcher ER, Howard AD, Robinson MK. Increased number of dendritic cells in draining lymph nodes accompanies the generation of contact photosensitivity. J. Invest. Dermatol.96(3), 355–361 (1991).
  • Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity23(6), 611–620 (2005).
  • Yoshiki R, Kabashima K, Sugita K, Atarashi K, Shimauchi T, Tokura Y. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J. Invest. Dermatol.129(3), 705–713 (2009).
  • Nishijima T, Tokura Y, Imokawa G, Takigawa M. Photohapten TCSA painting plus UVA irradiation of murine skin augments the expression of MHC class II molecules and CD86 on Langerhans cells. J. Dermatol. Sci.19(3), 202–207 (1999).
  • Hino R, Orimo H, Kabashima K et al. Evaluation of photoallergic potential of chemicals using THP-1 cells. J. Dermatol. Sci.52(2), 140–143 (2008).
  • Suzuki K, Yamazaki S, Tokura Y. Expression of T-cell cytokines in challenged skin of murine allergic contact photosensitivity: low responsiveness is associated with induction of Th2 cytokines. J. Dermatol. Sci.23(2), 138–144 (2000).
  • Moore DE. Drug-induced cutaneous photosensitivity: incidence, mechanism, prevention and management. Drug Saf.25(5), 345–372 (2002).
  • Hague JS, Ilchyshyn A. Lichenoid photosensitive eruption due to capecitabine chemotherapy for metastatic breast cancer. Clin. Exp. Dermatol.32(1), 102–103 (2007).
  • Hamanaka H, Mizutani H, Shimizu M. Sparfloxacin-induced photosensitivity and the occurrence of a lichenoid tissue reaction after prolonged exposure. J. Am. Acad. Dermatol.38(6 Pt 1), 945–949 (1998).
  • West AJ, Berger TG, LeBoit PE. A comparative histopathologic study of photodistributed and nonphotodistributed lichenoid drug eruptions. J. Am. Acad. Dermatol.23(4 Pt 1), 689–693 (1990).
  • Tokura Y, Seo N, Yagi H, Furukawa F, Takigawa M. Cross-reactivity in murine fluoroquinolone photoallergy: exclusive usage of TCR Vβ13 by immune T cells that recognize fluoroquinolone-photomodified cells. J. Immunol.160(8), 3719–3728 (1998).
  • Tokura Y, Seo N, Fujie M, Takigawa M. Quinolone-photoconjugated major histocompatibility complex class II-binding peptides with lysine are antigenic for T cells mediating murine quinolone photoallergy. J. Invest. Dermatol.117(5), 1206–1211 (2001).
  • Nishio D, Nakashima D, Mori T, Kabashima K, Tokura Y. Induction of eosinophil-infiltrating drug photoallergy in mice. J. Dermatol. Sci. (2009) (Epub ahead of print).
  • Sassolas B, Menard N, Guillet G. Photoallergic reactions to piroxicam and thiomersal sensitivity. Clin. Exp. Dermatol.19(2), 189 (1994).
  • Yokote R, Tokura Y, Igarashi N, Ishikawa O, Miyachi Y. Photosensitive drug eruption induced by flutamide. Eur. J. Dermatol.8(6), 427–429 (1998).
  • Sasaki T, Shimizu H, Tokuyama S et al. Antigenic characterization in ampiroxicam-induced photosensitivity using an in vivo model of contact hypersensitivity. J. Dermatol. Sci.21(3), 170–175 (1999).
  • Tokura Y, Seo N, Ohshima A, Yagi H, Furukawa F, Takigawa M. Lymphocyte stimulation test with drug-photomodified cells in patients with quinolone photosensitivity. J. Dermatol. Sci.21(1), 34–41 (1999).
  • Ohshima A, Seo N, Takigawa M, Tokura Y. Formation of antigenic quinolone photoadducts on Langerhans cells initiates photoallergy to systemically administered quinolone in mice. J. Invest. Dermatol.114(3), 569–575 (2000).
  • Izu K, Hino R, Isoda H, Nkashima D, Kabashima K, Tokura Y. Photocontact dermatitis to ketoprofen presenting with erythema multiforme. Eur. J. Dermatol.18(6), 710–713 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.